Novartis is to sell the US rights to market its overactive bladder treatment Enablex to Warner Chilcott. Novartis will receive …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

